COMPASS PATHWAYS
Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. It is conducting a large-scale psilocybin therapy clinical trial, in 20 sites across nine countries in Europe and North America. It was founded in 2016 and is based in Altrincham, Cheshire.
COMPASS PATHWAYS
Industry:
Biotechnology Health Care Life Science Personal Health Wellness
Founded:
2016-06-13
Address:
Altrincham, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.compasspathways.com
Total Employee:
11+
Status:
Active
Total Funding:
116.21 M USD
Technology used in webpage:
Google Font API Amazon IPv6 COVID-19 Apple Mobile Web App Capable Amazon Virginia Region Amazon S3 CDN Amazon CloudFront Java EE New Relic
Similar Organizations
Calibrate
Calibrate is a digital metabolic health business that is changing the way the world treats weight.
Libre Foods
Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet and animals.
LifeLens Technologies
LifeLens Technology is a biotechnology company that leads in innovative next generation treatment devices for personal health monitoring.
Mindfule
The Foodcare Company dedicated to improving brain and gut health through smart nutrition solutions.
Testmate Health
Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes.
SilverCloud Health
SilverCloud Health provides immediate access to evidence-based and supported digital therapies.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series B - COMPASS Pathways
Camden Partners
Camden Partners investment in Series B - COMPASS Pathways
Soleus Capital
Soleus Capital investment in Series B - COMPASS Pathways
McQuade Center for Strategic Research and Development
McQuade Center for Strategic Research and Development investment in Series B - COMPASS Pathways
Founders Fund
Founders Fund investment in Series B - COMPASS Pathways
Justin Mateen
Justin Mateen investment in Series B - COMPASS Pathways
ATAI Life Sciences
ATAI Life Sciences investment in Series B - COMPASS Pathways
Able Partners
Able Partners investment in Series B - COMPASS Pathways
Skyviews Life Science
Skyviews Life Science investment in Series B - COMPASS Pathways
WPSS.bio
WPSS.bio investment in Convertible Note - COMPASS Pathways
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-20 | COMPASS Pathways appoints Kebir Nath as chief executive |
| 2020-09-15 | Compass Pathways set to become the first psychedelic biotech IPO |
Official Site Inspections
http://www.compasspathways.com Semrush global rank: 500.13 K Semrush visits lastest month: 99.51 K
- Host name: 77.68.9.63
- IP address: 77.68.9.63
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "COMPASS Pathways" on Search Engine
Responsible organisation | Compass Pathways
Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. About us. Our purpose; Our stories; Our …See details»
Compass Pathways | LinkedIn
About us. We are COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first …See details»
Compass Pathways enters into research collaboration agreement …
January 16, 2024. Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational …See details»
Compass Pathways Announces Phase 3 Pivotal Program Design …
Oct 12, 2022 First ever phase 3 program of psilocybin therapy globally scheduled to begin in 2022. Compass Pathways plc (Nasdaq: CMPS), a mental health care company …See details»
Compass Pathways establishes research collaboration with …
LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access …See details»
Compass Pathways enters into research collaboration agreement …
LONDON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access …See details»
COMPASS Pathways announces positive topline results …
Nov 9, 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that its...See details»
Compass Pathways establishes research collaboration with …
May 2, 2024 Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for …See details»
COMPASS Pathways - Crunchbase Company Profile & Funding
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and …See details»
Investors | Investor Information | COMPASS Pathways plc
Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. About us. Our purpose. Our stories. Our …See details»
Compass Pathways and Journey Clinical establish research …
Apr 29, 2024 Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for …See details»
COMPASS Pathways - Psychedelic Science Review
COMPASS Pathways is a startup life science company focusing on the therapeutic benefits of psilocybin. The company was founded in London, UK in 2016 by Ekaterina …See details»
Pathways To Education - Compass CH
The award-winning Pathways to Education Program is provided to high school students living in low-income communities across Canada. Our program’s holistic combination of …See details»
SEC Filing | Compass Pathways plc
Sep 8, 2023 COMPASS Pathfinder Holdings Limited was originally incorporated under the laws of England and Wales in June 2017. Our registered office is located at 33 …See details»
These 2 Catalysts Could Soon Send Compass Pathways Stock …
May 21, 2024 Current Price. $7.92. Price as of May 20, 2024, 4:00 p.m. ET. Psychedelic medicines are rapidly gaining legitimacy on several fronts. As a psychedelic therapy …See details»
COMPASS Pathways plc (NASDAQ:CMPS) Q1 2024 Earnings …
May 13, 2024 COMPASS continues to maintain a strong financial position with cash and cash equivalents of $262.9 million at March 31, 2024. This compares with $220.2 million …See details»
COMPASS Pathways (CMPS) Earnings Date and Reports 2024
1 day ago CMPS Earnings Date and Information. COMPASS Pathways last posted its earnings results on May 8th, 2024. The reported ($0.55) EPS for the quarter, missing …See details»
Compass Pathways enters into research collaboration
LONDON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access …See details»
Compass Health Network | A Federally Qualified Health Center …
833-356-2427 (TOLL FREE) Compass Health Network. Through the delivery of compassionate, quality care, we help people find their way along a path to better …See details»
Behavioral Health | Compass Health Network
Behavioral Health | Compass Health Network. We enable balanced, healthy futures in the communities we serve. Through a process of continual improvement, we move beyond …See details»